Results 101 to 110 of about 110,931 (189)

Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer

, 2008
Thérèse H Franco, Ahmed Khan, Vishal Joshi, Beje ThomasDepartment of Internal Medicine, University of Connecticut, Farmington, CT, USAAbstract: Bevacizumab is a monoclonal antibody that inhibits vascular endothelial growth factor ...
Ahmed Khan, Vishal Joshi, Beje Thomas, Thérèse H Franco   +3 more
core  

Bevacizumab inhibits proliferation of choroidal endothelial cells by regulation of the cell cycle

, 2013
Raluca Rusovici, Chirag J Patel, Kakarla V ChalamUniversity of Florida, Department of Ophthalmology, Jacksonville, FL, USABackground: The purpose of this study was to evaluate cell cycle changes in choroidal endothelial cells treated with varying doses ...
Patel CJ, Rusovici R, Chalam KV
core  

Acute sterile endophthalmitis following intravitreal bevacizumab: case series

, 2014
Axel Orozco-Hernández,1 Ximena Ortega-Larrocea,1 Gustavo Sánchez-Bermúdez,1 Gerardo García-Aguirre,1 Virgilio Morales Cantón,1 Raul Velez-Montoya2 1Retina Department, Asociación para Evitar la Ceguera en M ...
Ortega-Larrocea X, Velez-Montoya R, Sánchez-Bermúdez G, Morales Canton V, García-Aguirre G, Orozco-Hernández A   +5 more
core  

Immediate effect of intravitreal injection of bevacizumab on intraocular pressure

, 2014
Ricardo Lemos-Reis,1 Nuno Moreira-Gonçalves,1 António B Melo,1 Ângela M Carneiro,1,2 Fernando M Falcão-Reis1,2 1Department of Ophthalmology of Hospital de São João, Porto, Portugal; 2Department of Sense Organs ...
Lemos-Reis R, Carneiro AM, Melo AB, Falcão-Reis FM, Moreira-Gonçalves N   +4 more
core  

Selective cTACE to a segment target hepatocellular carcinoma lesion during atezolizumab plus bevacizumab therapy achieving delayed hypovascularization and shrinkage of non-target intrahepatic lesions: a case report. [PDF]

Oxf Med Case Reports
Hara H, Matsumoto H, Yoshinaga A, Ishii H, Onodera K, Henta Y, Katsumata R, Fujii R, Yamamoto H, Ashikawa T, Sakaki K, Ito S, Asakawa T, Yoshino K, Sakita S.   +14 more
europepmc   +1 more source

First-line anlotinib versus bevacizumab plus CapeOX in RAS/BRAF wild-type unresectable metastatic colorectal cancer (ANCHOR): a multicenter, prospective, randomized, phase 3 trial. [PDF]

Signal Transduct Target Ther
Liu Y, Zhang Y, Lin R, Chen X, Wang J, Yang M, Qu X, Li Y, Li J, Zhang W, Mao Y, Wang Z, Liu Z, Lei J, Xu Y, Jiang Y, Pan Z, Zhu L, Liu C, Song M, Yuan Y, Ding K, ANCHOR Study Group.   +22 more
europepmc   +1 more source

Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting

, 2012
Angela M Carneiro,1,2 Luis S Mendonça,1 Manuel S Falcão,1,2 Sofia L Fonseca,1 Elisete M Brandão,1 Fernando M Falcão-Reis1,21Department of Ophthalmology of Hospital de São João, Porto ...
Falcão MS, Carneiro AM, Brandão EM, Mendonça LS, Fonseca SL, Falcão-Reis FM   +5 more
core  

Ivonescimab Plus Chemotherapy versus Bevacizumab Plus Chemotherapy in EGFR-Mutant Lung Adenocarcinoma After EGFR-TKI Failure: A Two-Center Retrospective Real-World Propensity Score-Matched Study. [PDF]

Drug Des Devel Ther
Zhou J, Wang Y, Wen K, Huang C, Huang D, Qin T, Li M, Su Y, Sun Y, Chen P.   +9 more
europepmc   +1 more source

Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results

, 2011
Mehmet Demir, Ersin Oba, Gökhan Gulkilik, Mahmut Odabasi, Erhan OzdalSisli Etfal Training and Research Hospital, Eye Clinic, Sisli, Istanbul, TurkeyPurpose: To present the functional and anatomic changes after intravitreal bevacizumab in eyes ...
Demir M, Ozdal E, Oba E, Gulkilik G, Odabasi M   +4 more
core  

Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers

, 2009
Jia Li, Muhammad Wasif SaifYale Cancer Center, Yale School of Medicine, New Haven CT, USAAbstract: Angiogenesis is essential for cancer growth and metastasis. Vascular endothelial growth factor (VEGF) is a key modulator of angiogenesis.
Jia Li, Muhammad Wasif Saif
core